Company Filing History:
Years Active: 2020-2025
Title: Maria Mycielska: Innovator in Cancer Diagnosis and Treatment
Introduction
Maria Mycielska is a prominent inventor based in Wuppertal, Germany. She has made significant contributions to the field of cancer research, particularly through her innovative patents. With a total of 2 patents, her work focuses on the diagnosis and treatment of cancer, showcasing her dedication to advancing medical science.
Latest Patents
One of Maria Mycielska's latest patents is centered around the plasma membrane citrate transporter (pmCiC) for use in the diagnosis and treatment of cancer. This invention outlines a method for diagnosing cancer that involves pmCiC. Additionally, it introduces a modified substrate or modulator of pmCiC, highlighting its potential as a tumor marker. The patent also details a method for screening modulators of pmCiC activity, emphasizing its importance in cancer research.
Career Highlights
Maria Mycielska is affiliated with Universitätsklinikum Regensburg, where she continues her research and development efforts. Her work has garnered attention in the scientific community, contributing to advancements in cancer diagnostics and treatment methodologies.
Collaborations
Throughout her career, Maria has collaborated with notable colleagues, including Edward Geissler and Petra Rümmele. These partnerships have further enriched her research and expanded the impact of her innovations.
Conclusion
Maria Mycielska stands out as a dedicated inventor in the realm of cancer research. Her innovative patents and collaborative efforts reflect her commitment to improving diagnostic and treatment options for cancer patients.